Drugs Made In America Acquisition Corp. · NASDAQ:DMAA

Glazer Capital, LLC reported a 5.44% stake in Drugs Made In America Acquisition Corp. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Glazer Capital, LLC reported a 5.44% stake in Drugs Made In America Acquisition Corp., 1,822,952 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
5.44%
Shares
1,822,952
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Glazer Capital, LLC5.44%1,822,952
Paul J. Glazer5.44%1,822,952

Source

View original at SEC

Related